Bio Essence Corporation Share Price

Equities

BIOE

US09090C1053

Pharmaceuticals

Delayed OTC Markets 11:52:14 23/01/2024 pm IST 5-day change 1st Jan Change
0.26 USD -49.02% Intraday chart for Bio Essence Corporation -.--% -49.02%
Sales 2022 986K 82.24M Sales 2023 552K 46.01M Capitalization 19.38M 1.62B
Net income 2022 - 0 Net income 2023 - 0 EV / Sales 2022 23.1 x
Net Debt 2022 4.61M 385M Net Debt 2023 3.48M 290M EV / Sales 2023 41.5 x
P/E ratio 2022
-22.4 x
P/E ratio 2023
-18.9 x
Employees 12
Yield 2022 *
-
Yield 2023
-
Free-Float 21.07%
More Fundamentals * Assessed data
Dynamic Chart
Bio Essence Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Health Up, Inc acquired Bio Essence Herbal Essentials, Inc. from Bio Essence Corporation on for $0.4 million CI
Newways, Inc. completed the acquisition of Bio Essence Pharmaceutical, Inc. from Bio Essence Corporation. CI
Bio Essence Corporation Announces Resignation of Sharon Mair from the Board of Directors CI
Newways, Inc. agreed to acquire Bio Essence Pharmaceutical, Inc. from Bio Essence Corporation for $0.3 million. CI
Bio Essence Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Bio Essence Corporation Appoints William E. Sluss as Chief Financial Officer CI
Bio Essence Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Bio Essence Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Bio Essence Corporation Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Bio Essence Corporation Auditor Raises 'Going Concern' Doubt CI
Bio Essence Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
Bio Essence Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
Bio Essence Corporation Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Bio Essence Corporation Reports Earnings Results for the Full Year Ended December 31, 2021 CI
More news
1 day-49.02%
6 months-49.02%
Current year-49.02%
More quotes
Current year
0.26
Extreme 0.26
0.26
1 year
0.25
Extreme 0.245
1.25
3 years
0.25
Extreme 0.245
1.25
5 years
0.25
Extreme 0.245
1.25
10 years
0.25
Extreme 0.245
1.25
More quotes
Managers TitleAgeSince
Chief Executive Officer 48 -
Chief Operating Officer 50 -
Sales & Marketing 48 -
Members of the board TitleAgeSince
Chief Executive Officer 48 -
Director/Board Member 43 -
Director/Board Member 53 -
More insiders
Bio Essence Corp. is a herbal health, diet, and nutrition company. The Company operates through its subsidiaries, including Bio Essence Pharmaceutical, Inc. (BEP), Bio Essence Herbal Essentials Inc. (BEH), and McBE Pharma, Inc. (McBE). The primary focus of BEP is producing products for BEH and McBE, along with providing original equipment manufacturing and private label services to other companies. BEH targets and develops traditional Chinese medicines (TCM) in the form of single herbs, granules, pills, and tablets. It also offers special formulated dietary supplements and medical food. The Company sells its products through channels, such as TCM practitioners, online Websites, including its own Website, and brick-and-mortar stores, such as GNC. The Company also focuses on providing customers direct connections with integrative healthcare practitioners such as dietitians, nutraceutical practitioners, and other practitioners in this discipline worldwide.
More about the company